Latest KFF Health News Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Drug-Pricing Policies Find New Momentum As ‘A 2020 Thing’
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.
Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Extreme Temperatures May Pose Risks To Some Mail-Order Meds
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son — and others who order medicine by mail — could depend on it, she says.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
When Medicine Makes Patients Sicker
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers.
Podcast: KHN’s ‘What The Health?’ Ask Us Anything!
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners’ questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner.
How Sen. Orrin Hatch Changed America’s Health Care
Utah’s Orrin Hatch is leaving the Senate, after 42 years. The Republican led bipartisan efforts to provide health care to more kids and AIDS patients. He also thrived on donations from the drug industry.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
For The Asking, A Check Is In The Mail To Help Pay For Costly Drugs
It’s a little-known secret that patients can get thousands of dollars directly from a drugmaker.
Government Investigation Finds Flaws In the FDA’s Orphan Drug Program
A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ Reading The Tea Leaves In Blue Wave’s Wake
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”
